The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSurface Transforms Regulatory News (SCE)

Share Price Information for Surface Transforms (SCE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.275
Bid: 1.25
Ask: 1.30
Change: 0.00 (0.00%)
Spread: 0.05 (4.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.275
SCE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing

8 Dec 2009 07:00

RNS Number : 7036D
Surface Transforms PLC
08 December 2009
 



Surface Transforms Plc

("Surface Transforms" or "the Company")

 Placing 

Introduction

The Company today announces that it has conditionally placed with certain existing shareholders, including directors and senior management of the Company, 800,000 new ordinary shares ("Placing Shares") of 1p each ("Ordinary Shares") at a price of 10p per share thereby raising gross proceeds of £80,000 (the "Placing"). The proceeds will provide specific capital to finance the investment in additional working capital related to the Company's carbon vapour infiltration (CVI) process. The CVI manufacturing stage is a key part of the Company's proprietary process for manufacturing silicon carbide brake discs and components.

The Placing Shares will represent approximately 3.29 per cent of the Company's enlarged share capital.

Background to and reasons for the Placing

A number of existing shareholders had expressed interest in further investment in the Company and this coincided with a need to increase the levels of inventory of 'mission critical' components and spares relating to the CVI process. The newly commissioned CVI process is a critical stage in the manufacture of silicon carbide components and process downtime is minimised by having 'mission critical' inventory and spares available at all times.

Issue of New Shares

The Placing is solely conditional upon Admission of the Placing Shares to AIM.

Application will be made to the London Stock Exchange for the Placing Shares to be admitted to trading on AIM. It is expected that such Admission will become effective and that dealings will commence on or around 15th December 2009.

The Placing Shares will, when issued, rank pari passu in all respects with the existing Ordinary Shares, including the right to receive dividends and other distributions declared following Admission. 

Directors' Participation in the Placing

The following Directors participated in the Placing and their holdings are detailed below:

Name

Number of Existing Ordinary Shares

Percentage of existing voting share capital

Number of Shares following the Placing

Percentage of existing voting share capital following the Placing

Dr.Kevin Johnson

79,750

0.34%

104,750

0.43%

Kenneth Baker

115,000

0.49%

215,000

0.88%

Richard Gledhill

6,828,723

29.00%

7,072,223

29.05%

In addition, two members of the senior management team also participated in the Placing and in total directors and management of the Company invested £44,500 of the £80,000 Placing funds.

Total Voting Rights

For the purposes of the Disclosure and Transparency Rules, the Company's total issued share capital following the completion of the Placing will consist  of 24,347,328 ordinary shares of 1p each with one voting right per share. There are no shares held in treasury. 

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the Disclosure and Transparency Rules.

Enquiries:

Surface Transforms Plc
+44 (0) 151 356 2141
Dr. Kevin Johnson, CEO
 
Geoff Hall, Company Secretary
 
 
 
Seymour Pierce Limited
+ 44 (0) 207 107 8000
Corporate Finance
 
Nandita Sahgal
 
Christopher Wren
 
 
 
Corporate Broking
 
Paul Jewell
 

 

Seymour Pierce Limited, which is regulated by the Financial Services Authority and is a member of the London Stock Exchange, is acting as nominated adviser and broker exclusively for the Company in connection with the Placing. Its responsibilities as the Company's nominated adviser under the AIM Rules are owed solely to the London Stock Exchange and are not owed to the Company or to any Director or any other person in respect of his decision to acquire ordinary shares in the Company in reliance on any part of this announcement. No representation or warranty, express or implied, is made by Seymour Pierce Limited as to any of the contents of this announcement for which the Directors and the Company are responsible (without limiting the statutory rights of any person to whom this announcement is issued). Seymour Pierce Limited has not authorised the contents of, or any part of, this announcement, and no liability whatsoever is accepted by Seymour Pierce Limited for the accuracy of information or opinions contained in this announcement or for the omission of any material information. Seymour Pierce Limited will not be offering advice and will not otherwise be responsible for providing customer protections to recipients of this announcement in respect of the Placing or any acquisition of shares in the Company.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IOEZDLFBKLBLFBL
Date   Source Headline
22nd Oct 20204:44 pmRNSDirector Dealing
21st Oct 20207:00 amRNSGrant of Options
6th Oct 20203:37 pmRNSPDMR dealing
6th Oct 20203:26 pmRNSDirector dealing
6th Oct 20203:00 pmRNSDirector Dealing
28th Sep 20207:00 amRNSHalf-year results for 6 months ended 30 June 2020
15th Sep 20203:15 pmEQSHardman & Co Research: Surface Transforms (SCE): A whole new level of contract winning
15th Sep 20208:42 amRNSHolding(s) in Company
15th Sep 20207:00 amRNSCorporate presentation
14th Sep 20207:00 amRNSContract Award from OEM 8 and Trading Update
31st Jul 20203:35 pmRNSHolding(s) in Company
24th Jul 20206:28 pmRNSResult of Annual General Meeting
20th Jul 20207:00 amRNSTrading Statement & Investor Presentation
2nd Jul 20207:00 amRNSChange of Adviser
26th Jun 202010:31 amRNSPosting of Annual Report and Notice of AGM
25th Jun 20207:00 amRNSPDMR Dealing
22nd Jun 20207:00 amRNSPreliminary Results and Notice of AGM
17th Jun 20207:00 amRNSReporting timetable
8th Jun 20207:00 amRNSKoenigsegg Contract Award
1st Jun 202011:47 amRNSHolding(s) in Company
1st Jun 20207:00 amRNSDirector Dealing
29th May 20204:51 pmRNSHolding(s) in Company
29th May 20201:17 pmRNSHolding(s) in Company
26th May 20204:01 pmRNSHolding(s) in Company
21st May 20209:30 amRNSResult of General Meeting and TVR
18th May 20207:00 amRNSResult of Excess Open Offer
5th May 20208:30 amRNSLetter to Shareholders & Notice of GM
4th May 20207:00 amRNSOpen Offer Excess
1st May 20207:00 amRNSResult of over-subscribed open offer
24th Apr 20204:17 pmRNSHolding(s) in Company
23rd Apr 202011:35 amEQSHardman & Co Research: Q&A with Mike Foster on Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
21st Apr 20207:00 amRNSOpen Offer application form - update
20th Apr 202010:20 amRNSHolding(s) in Company
17th Apr 20203:15 pmEQSHardman & Co Research: Surface Transforms (SCE): High visibility for 2021 onwards; equity raise
9th Apr 20203:00 pmRNSPlacing and Open Offer
27th Mar 20207:00 amRNSDeferral of Publication of Results &COVID19 Update
28th Feb 20207:00 amRNSUnaudited interims for the 6 m/e 30 November 2019
10th Feb 20208:27 amRNSHolding(s) in Company
28th Jan 20205:30 pmRNSAppointment of Sales Director and Grant of Options
27th Jan 20202:00 pmRNSDirector/PDMR Shareholding
10th Jan 20207:00 amRNSTrading and operational update
5th Dec 20197:00 amRNSGrant of options
13th Nov 20198:33 amRNSExercise of options
13th Nov 20198:27 amRNSResult of AGM
6th Nov 201910:01 amRNSHolding(s) in Company
6th Nov 20199:00 amRNSExercise of Options and PDMR Dealing
25th Oct 201912:56 pmEQSHardman & Co Research : Surface Transforms (SCE): Recent major contract wins transform prospects
17th Oct 20197:00 amRNSPosting of Annual Report and Notice of AGM
2nd Oct 201910:55 amRNSDirector/PDMR Shareholding
26th Sep 20197:00 amRNSContract award from OEM 1

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.